Table 3.
Predictive Factor Analysis for Overall Survival (After Matching)
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Age (> 60 years) | 1.00 (0.53–1.89) | 0.997 | ||
| Sex (female) | 0.683 (0.09–4.99) | 0.707 | ||
| Child–Pugh class (B) | 3.48 (1.04–11.62) | 0.043 | 2.12 (0.58–7.63) | 0.252 |
| AFP (> 400 ng/mL) | 3.74 (1.97–7.12) | < 0.001 | 2.17 (1.06–4.45) | 0.034 |
| Number of tumors (> 3) | 6.93 (3.28–14.72) | < 0.001 | 5.07 (2.21–11.61) | < 0.001 |
| Maximum tumor diameter (> 7 cm) | 2.09 (1.12–3.89) | 0.021 | 1.54 (0.79–3.00) | 0.201 |
| PVTT (Present) | 1.91 (0.93–3.92) | 0.076 | 1.12 (0.52–2.41) | 0.776 |
| TACE-lenvatinib | 0.45 (0.21–0.99) | 0.048 | 0.38 (0.17–0.85) | 0.018 |
Abbreviations: HR, hazard ratio; AFP, α-fetoprotein; PVTT, portal vein tumor thrombus; TACE, transarterial chemoembolization; HR, hazard ratio; CI, confidence interval.